Metronom Health is an early stage medical device company, focusing on developing an innovative, opto-enzymatic continuous blood glucose monitoring technology, for people living with diabetes. Metronom's proprietary technology is believed to provide very significant improvements over available Continuous Glucose monitoring technologies, in terms of accuracy in the hypo-glycemic range, reliability, user friendliness, at a price for the user amenable to a broader adoption and easier coverage. Metromom Health was founded in 2010, and has since successfully developped a human grade commercial prototype of its system, and completed a First in Human study confirming the performance of the technology. The company is now at a turning point of its short history, combining its focus on engineering and R&D to the development of a product that will be solidly achored into responding to the needs of the users, as well as the people caring for them. The company was founded in Laguna Hills, California and we are opening a facility in Belgium in anticipation of the commercial release planned early 2019 the Europe.